Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The study will assess the long-term safety of the fixed combination product QVA149 versus placebo and a standard of care treatment (tiotropium) in Chronic Obstructive Pulmonary Disease (COPD) patients with moderate to severe airflow limitation.
Epistemonikos ID: e78c812c594e21e21728c741b0c70f31476d998b
First added on: Jun 24, 2019